Campbell Vyvyan 4
4 · PetLife Pharmaceuticals, Inc. · Filed Mar 20, 2018
Insider Transaction Report
Form 4
Campbell Vyvyan
Director10% Owner
Transactions
- Purchase
Common Stock
2018-02-28$4017.00/sh+305,000$1,225,185,000→ 1,305,000 total
Footnotes (1)
- [F1]Purchased stock.